Companion Animal Health Market Report 2025: Competitive Strategies And Forecasts 2023-2033 - Zoetis Leads With Diversified Portfolio As Boehringer Ingelheim Expands Vaccines And Anti-Parasitics

(MENAFN- GlobeNewsWire - Nasdaq) The companion animal health market is poised for growth due to rising pet humanization, preventive healthcare adoption, and digital health integration. Key opportunities include expanding diagnostic and telehealth services, addressing high veterinary costs and insurance gaps, and enhancing skilled workforce availability in underserved regions.

Dublin, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The "Companion Animal Health Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033" report has been added to ResearchAndMarkets's offering.
The companion animal health market is witnessing robust growth, with a Compound Annual Growth Rate (CAGR) estimated at 9.2% during the forecast period from 2025 to 2033.

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

The rising global pet population, coupled with increasing human-animal bonding, is a major driver, leading to higher demand for quality veterinary care. Advances in veterinary diagnostics and the availability of innovative treatment options have expanded the scope of preventive and therapeutic solutions.
In 2024, North America emerged as the dominant region in terms of revenue share in the global companion animal health market, driven by a combination of high pet ownership rates, advanced veterinary infrastructure, and the strong presence of leading market players with well-established distribution and service networks. The United States, in particular, led the region's growth due to increased expenditure on veterinary care, widespread adoption of pet insurance, and the availability of technologically advanced diagnostic and therapeutic options. Government data from the U.S. Department of Agriculture indicated that nearly 70% of U.S.
households owned at least one pet in 2024, contributing to sustained demand for pharmaceuticals, diagnostics, and preventive healthcare products. Europe followed closely, with strong revenues from countries such as Germany, the UK, and France, where stringent animal welfare regulations and mandatory vaccination policies supported consistent product consumption. Western Europe benefited from high awareness levels and the widespread integration of veterinary telehealth services, while Eastern Europe saw growth driven by the modernization of veterinary clinics.
Competitive Trends and Key Strategies
In 2024, the companion animal health market was characterized by intense competition among established players, with companies focusing on innovation, geographic expansion, strategic partnerships, and product diversification to maintain their market positions. Zoetis Services LLC led the market in terms of revenue, leveraging its broad product portfolio across pharmaceuticals, diagnostics, and vaccines, along with ongoing investments in R&D for next-generation biologics and digital platforms. Boehringer Ingelheim International GmbH focused on expanding its vaccine and anti-parasitic portfolios through continuous innovation and targeted acquisitions in emerging markets.
Elanco pursued aggressive cost optimization and integration strategies following previous acquisitions, with an emphasis on expanding its diagnostics and parasiticides range. IDEXX Laboratories, Inc. maintained leadership in veterinary diagnostics, capitalizing on rising demand for point-of-care testing and AI-enabled imaging solutions. Merck & Co., Inc. strengthened its position through steady product development and global distribution channel enhancements. Ceva and Virbac invested in the development of companion animal vaccines and nutraceuticals, with a focus on broadening their presence in Asia Pacific and Latin America.
Vetoquinol and Norbrook prioritized value-based offerings and strategic alliances with local distributors to deepen market penetration in cost-sensitive regions. Indian Immunologicals Ltd. concentrated on expanding affordable vaccine access in South Asia and Africa, supported by government and institutional partnerships. Agrolabo S.p.A. capitalized on niche diagnostic and vaccine needs in the European market.
Across the competitive landscape, companies are expected to increase investment in digital health platforms, including telemedicine and electronic health records, while accelerating R&D for biologics, long-acting formulations, and species-specific innovations. Strategic licensing deals, mergers and acquisitions, and collaborations with veterinary clinics and academic institutions are also expected to intensify during the forecast period from 2025 to 2033, as firms seek to strengthen their product pipelines and adapt to changing consumer behavior and regulatory standards globally.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Companion Animal Health market?
• What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2033.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Companion Animal Health market?
• Which is the largest regional market for Companion Animal Health market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Companion Animal Health market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Companion Animal Health market worldwide?

Companies Featured

• Agrolabo S.p.A.
• Boehringer Ingelheim International GmbH
• Ceva
• Elanco
• IDEXX Laboratories, Inc.
• Indian Immunologicals Ltd.
• Merck & Co., Inc.
• Norbrook
• Vetoquinol
• Virbac
• Zoetis Services LLC

Market Segmentation

Animal

• Dogs
• Equine
• Cats
• Others

Product

• Vaccines
• Pharmaceuticals
• OTC
• Prescription
• Feed Additives
• Diagnostics
• Others

Distribution Channel

• Retail
• E-commerce
• Hospital pharmacies

End-Use

• Point-of-care/In-house testing
• Hospitals & Clinics
• Others

Region Segment (2023 - 2033; US$ Million)

• North America
• U.S.
• Canada
• Rest of North America
• UK and European Union
• UK
• Germany
• Spain
• Italy
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa
• GCC
• Africa
• Rest of Middle East and Africa

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN30092025004107003653ID1110131532